D.E. Shaw & Co’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.1M | Buy |
|
|||||
|
2025
Q1 | $7.37M | Sell |
|
|||||
|
2024
Q4 | $13.1M | Sell |
|
|||||
|
2024
Q3 | $28M | Sell |
|
|||||
|
2024
Q2 | $31.3M | Buy |
|
|||||
|
2024
Q1 | $24.1M | Buy |
|
|||||
|
2023
Q4 | $942K | Sell |
|
|||||
|
2023
Q3 | $1.01M | Buy |
|
|||||
|
2023
Q2 | $987K | Buy |
|
|||||
|
2023
Q1 | $955K | Sell |
|
|||||
|
2022
Q4 | $1.36M | Sell |
|
|||||
|
2022
Q3 | $3.06M | Sell |
|
|||||
|
2022
Q2 | $3.82M | Buy |
|
|||||
|
2022
Q1 | $4.16M | Sell |
|
|||||
|
2021
Q4 | $6.75M | Buy |
|
|||||
|
2021
Q3 | $6.15M | Buy |
|
|||||
|
2021
Q2 | $1.01M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $36K | Sell |
|
|||||
|
2019
Q2 | $53K | Sell |
|
|||||
|
2019
Q1 | $520K | Buy |
|
|||||
|
2018
Q4 | $15K | Sell |
|
|||||
|
2018
Q3 | $138K | Sell |
|
|||||
|
2018
Q2 | $163K | Sell |
|
|||||
|
2018
Q1 | $806K | Buy |
|
|||||
|
2017
Q4 | $761K | Buy |
|
|||||
|
2017
Q3 | $306K | Buy |
|
|||||
|
2017
Q2 | $46K | Sell |
|
|||||
|
2017
Q1 | $213K | Sell |
|
|||||
|
2016
Q4 | $2M | Sell |
|
|||||
|
2016
Q3 | $4.51M | Buy |
|
|||||
|
2016
Q2 | $292K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $1.48M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $1.76M | Sell |
|
|||||
|
2015
Q1 | $2.98M | Sell |
|
|||||
|
2014
Q4 | $2.88M | Buy |
|
|||||
|
2014
Q3 | $1.31M | Buy |
|
|||||
|
2014
Q2 | $860K | Buy |
|
|||||
|
2014
Q1 | $794K | Sell |
|
|||||
|
2013
Q4 | $1.87M | Buy |
|
|||||
|
2013
Q3 | $911K | Sell |
|
|||||
|
2013
Q2 | $908K | Buy |
|